The evaluation of effects of Daflon tablet on hemorrhoids
Not Applicable
- Conditions
- Hemorrhoids.Hemorrhoids and perianal venous thrombosis
- Registration Number
- IRCT20210625051698N1
- Lead Sponsor
- Karaj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Patients over the age of 18 years old who were diagnosed with grade 3 or 4 of hemorrhoids based on a surgeons' physical exam and history taking
Exclusion Criteria
Does not have a history of previous treatment of hemorrhoids.
Does not have a history of consumption or allergy to Daflon tablet.
Does not have a history of renal failure or electrolytes imbalance.
Does not have a serious underlying disease, including immunodeficiency disease, hyperparathyroidism, complete heart block, addison's disease, intestinal disorders, or malignancies.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of improvements of sign and symptoms. Timepoint: 4 weeks after inclusion. Method of measurement: Duration of times that takes for patients for their signs to get improved.;Severity of sign and symptoms. Timepoint: 4 weeks after inclusion. Method of measurement: The severity of symptoms are going to get reported by patients 4 weeks after inclusion based on visual Analogue scale.;Relapse of sign and symptoms. Timepoint: 4 weeks after inclusion. Method of measurement: In case of resolution of symptoms in 4 weeks, patients report relapse of their symptoms.
- Secondary Outcome Measures
Name Time Method